Lung carcinoma: genes and variants
Explore variant evidence for Lung carcinoma across 4 analyzed proteins (BRAF, CHEK2, EGFR, TERT). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 1 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Lung carcinoma
BRAF: Serine/threonine-protein kinase B-raf
It relays activated RAS signals through MEK and ERK to control proliferation, differentiation, and survival. Activating variants, especially V600E, drive melanoma and several other cancers and create sensitivity to pathway-directed therapies.
2 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in BRAF have source records linked to Lung carcinoma. Association strength is not clinical gene validity.
CHEK2: Serine/threonine-protein kinase Chk2
It propagates DNA-damage checkpoint signals to proteins controlling cell-cycle arrest, repair, and apoptosis. Germline loss-of-function variants confer moderate cancer susceptibility, especially for breast cancer, while risk estimates depend on the specific allele and family context.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in CHEK2 have source records linked to Lung carcinoma. Association strength is not clinical gene validity.
EGFR: Epidermal growth factor receptor
A cell-surface receptor tyrosine kinase that responds to epidermal-growth-factor family ligands. Ligand binding activates phosphorylation cascades that regulate cell growth, survival, and differentiation, which is why EGFR changes are important in cancer biology.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in EGFR have source records linked to Lung carcinoma. Association strength is not clinical gene validity.
TERT: Telomerase reverse transcriptase
It extends telomeric DNA using an internal RNA template and helps counter progressive chromosome-end shortening in stem and proliferative cells. Loss-of-function variants cause telomere-biology disorders, while promoter activation and increased activity support unlimited proliferation in many cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TERT have source records linked to Lung carcinoma. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): MET, PPM1D and PRKN.
ClinVar pathogenic and likely pathogenic variants linked to Lung carcinoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| BRAF N581K | 581 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| BRAF D638E | 638 | Protein kinase | Pathogenic / likely pathogenic (★★) |
Same protein, different disease
- RASopathy also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lung carcinoma variants (36 pathogenic / likely pathogenic).
- Cardio-facio-cutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lung carcinoma variants (26 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lung carcinoma variants (17 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lung carcinoma variants (11 pathogenic / likely pathogenic).
- Noonan syndrome and Noonan-related syndrome also has ClinVar records linked to BRAF variants; they fall mostly in different places as the Lung carcinoma variants (10 pathogenic / likely pathogenic).
Diseases related to Lung carcinoma
- Colorectal cancer, also linked to BRAF, CHEK2 and EGFR
- Lung adenocarcinoma, also linked to BRAF, EGFR and TERT
- Urinary bladder cancer, also linked to EGFR and TERT
- Non-small cell lung carcinoma, also linked to BRAF and EGFR
- Melanoma, cutaneous malignant, also linked to BRAF and TERT
- Lung cancer, also linked to BRAF and EGFR
- Hepatocellular carcinoma, also linked to BRAF and TERT
- Prostate cancer, also linked to CHEK2 and TERT
- Prostate cancer, hereditary, also linked to BRAF and CHEK2
- Hypertrophic cardiomyopathy, also linked to BRAF
- RASopathy, also linked to BRAF
- Lynch syndrome, also linked to CHEK2
Frequently asked questions
Which genes have records linked to Lung carcinoma?
This view contains 4 analyzed proteins: BRAF, CHEK2, EGFR, TERT. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 1 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 7 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center